Notizie

Più notizie

  • 14.04.2021

    The vaccine disrupting the pharma industry

    UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.

  • 08.04.2021

    Policymaking in the post-pandemic era

    Institutional Money (06.04.2021) - The unprecedented nature of the pandemic paved the way for aggressive and, at times, unorthodox stimulus measures; however, these were crucial for ensuring smooth market functioning and delivering accommodative financial conditions at the height of the crisis.

  • 01.04.2021

    Short-term downside risks for gold

    Bilan (31.03.2021) - As vaccines offer a way out of the current crisis, we should see a greater rebound among small and mid-cap companies, the so-called ‘SMID-cap’ segment, than in the broader market.

  • 30.03.2021

    How finance can fight the climate crisis

    Good With Money (19.03.2021) – Mathieu Nègre, Head of Global Emerging Markets at UBP, recently took part in a Good With Money podcast, a series in which experts discuss current ethical investment trends.

  • 24.03.2021

    Gestione discrezionale – le redini sono in mano vostra

    Ogni cliente ha aspirazioni e obiettivi unici, così come è unico il nostro approccio alla gestione di portafoglio discrezionale.

  • 22.03.2021

    Short-term downside risks for gold

    Finanz und Wirtschaft (20.03.2021) - Gold prices declined in recent weeks to lows of around $1,680 per ounce. The cause was the continued steepening of the US yield curve.

Our latest podcasts

Our latest podcasts

Subscribe to our newsletters